Fig. 1: Randomized trial profile.
CONSORT diagram for the disposition of KEN SHE Study participants, including primary mITT cohort disposition for HPV 16/18 and HPV 16/18/31/33/45/52/58.
Fig. 1: Randomized trial profile. | Nature Medicine
CONSORT diagram for the disposition of KEN SHE Study participants, including primary mITT cohort disposition for HPV 16/18 and HPV 16/18/31/33/45/52/58.
